FORCE's eXamining the Relevance of Articles for You (XRAY) program looks behind the headlines of cancer news to help you understand what the research means for you.
XRAY is a reliable source of hereditary cancer research-related news and information.
Learn more about the XRAY program
Prostate Cancer
Relevance: Medium-High
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-simple.png)
Strength of Science: High
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-simple.png)
Research Timeline: Human Research
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-research-cycle3.png)
Study : Promising early results for treating metastatic prostate cancer
Relevance: Medium-High
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-simple.png)
Strength of Science: High
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-simple.png)
Research Timeline: Human Research
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-research-cycle3.png)
Most relevant for: People with metastatic castration-resistant prostate cancer (mCRPC)
The TALAPRO studies looked at how well the oral drug Talzenna (talazoparib) works as a treatment for metastatic castration-resistant prostate cancer (mCRPC). The addition of Talzenna to treatment with Xtandi (enzalutamide) increased the time until the cancer got worse or came back (progression-free survival). The greatest benefit was seen in people who had an inherited or tumor mutation in a gene that repairs DNA damage (such as ATM, BRCA1, BRCA2 and others). (Posted 3/1/23)
Update: On June 20, 2023, the Food and Drug Administration (FDA) approved the combination of Talzenna with Xtandi as an initial treatment for some people with mCRPC for people with inherited or tumor mutations in genes that repair DNA damage.
Este artículo está disponible en español.
Read More![](https://www.facingourrisk.org/cdn-cgi/image/width=400,height=400,fit=contain,format=webp/uploads/assets/xray/63ffdd7ce2078.jpg)
Study : Increasing soy in your diet may lower your cancer risk
Most relevant for: People interested in reducing cancer risk
This study looked at a link between a diet rich in soy and cancer risk. With the addition of more recent literature, this study suggests that soy lowers the risk of cancer in the general population. (Posted 2/24/23)
Este artículo está disponible en español.
Read More![](https://www.facingourrisk.org/cdn-cgi/image/width=400,height=400,fit=contain,format=webp/uploads/assets/xray/63f8df4e47eea.jpg)
Topic : Cancer disparities in American Indian and Alaska Native populations
Most relevant for: Americans Indians and Alaska Natives
The American Cancer Society released a special section in their 2022 Cancer Facts & Figures report that discussed cancer disparities in American Indian and Alaska Native populations in the United States. This review highlights the special section’s main points, including disparities in cancer screening, diagnosis and survival rates in native communities, as well as factors contributing to those disparities. (Posted 12/20/22)
Este artículo está disponible en español.
Read More![](https://www.facingourrisk.org/cdn-cgi/image/width=400,height=400,fit=contain,format=webp/uploads/assets/xray/63a1cb8247e03.jpg)
Relevance: Medium-High
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-simple.png)
Strength of Science: High
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-simple.png)
Research Timeline: Post Approval
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-research-cycle3.png)
Guideline : Guidelines on exercise, diet, and weight during cancer treatment
Relevance: Medium-High
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-simple.png)
Strength of Science: High
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-simple.png)
Research Timeline: Post Approval
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-research-cycle3.png)
Most relevant for: People currently undergoing treatment for cancer
Most professional guidelines on exercise, diet and weight management have focused on the health of the general population and cancer survivors. The American Society of Clinical Oncology (ASCO) has now published evidence-based recommendations for exercise, diet and weight specifically for people who are in active treatment for cancer. (Posted 11/29/22) Este artículo está disponible en español.
Read More![](https://www.facingourrisk.org/cdn-cgi/image/width=400,height=400,fit=contain,format=webp/uploads/assets/xray/6386a8f425470.jpg)
Relevance: High
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-simple.png)
Strength of Science: Medium-High
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-simple.png)
Research Timeline: Human Research
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-research-cycle3.png)
Study : Prostate cancer screening may benefit people with Lynch syndrome
Relevance: High
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-simple.png)
Strength of Science: Medium-High
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-simple.png)
Research Timeline: Human Research
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-research-cycle3.png)
Most relevant for: People with Lynch syndrome
Initial results from the IMPACT trial show that PSA testing to screen for prostate cancer in people with Lynch syndrome can detect aggressive early prostate cancers. These findings support the use of PSA screening in men with Lynch syndrome, particularly men with an inherited mutation in an MSH2 or MSH6 gene. (Posted 11/10/22)
Este artículo está disponible en español.
Read More![](https://www.facingourrisk.org/cdn-cgi/image/width=400,height=400,fit=contain,format=webp/uploads/assets/xray/636d760468fa6.jpg)
Relevance: Medium-High
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-simple.png)
Strength of Science: Medium-High
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-simple.png)
Study : Teens and young adults respond well to learning about familial cancer risk
Relevance: Medium-High
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-simple.png)
Strength of Science: Medium-High
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-simple.png)
Most relevant for: Mothers who have had genetic testing for BRCA1 or BRCA2 whether or not they have been diagnosed with breast or ovarian cancer
Little is known about how awareness of hereditary cancer in a high-risk family affects the quality of life of teens and young adults. This study looked at the lifestyle choices, cancer awareness and quality of life of adolescents and young adults whose mothers had undergone testing for a BRCA mutation. (Posted 10/11/2022) Este artículo está disponible en español.
Read More![](https://www.facingourrisk.org/cdn-cgi/image/width=400,height=400,fit=contain,format=webp/uploads/assets/xray/6345875e58a63.jpg)
Relevance: Medium-High
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-simple.png)
Strength of Science: Medium-High
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-simple.png)
Research Timeline: Human Research
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-research-cycle3.png)
Study : PARP inhibitor treatment for metastatic prostate cancer shows most benefit in men with inherited BRCA mutations
Relevance: Medium-High
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-simple.png)
Strength of Science: Medium-High
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-simple.png)
Research Timeline: Human Research
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-research-cycle3.png)
Most relevant for: People with metastatic castration resistant prostate cancer who have an inherited or tumor mutation in BRCA2.
This study looked at the benefit of using the PARP inhibitor niraparib to treat metastatic castration-resistant prostate cancer (mCRPC). Participants included those with an inherited or tumor mutation in BRCA1 or BRCA2 or an inherited or tumor mutation in another gene that affects DNA repair. Participants with an inherited or tumor mutation in BRCA1 or BRCA2 had better survival compared to those without a BRCA mutation. Side effects from niraparib were common, and consistent with previous reports for PARP inhibitors. (posted 9/6/2022)
Este artículo está disponible en español.
Read More![](https://www.facingourrisk.org/cdn-cgi/image/width=400,height=400,fit=contain,format=webp/uploads/assets/xray/631779a4ac864.jpg)
Relevance: Medium-High
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-simple.png)
Strength of Science: High
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-simple.png)
Research Timeline: Post Approval
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-research-cycle3.png)
Study : Physical activity may decrease fatigue associated with cancer treatment
Relevance: Medium-High
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-simple.png)
Strength of Science: High
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-simple.png)
Research Timeline: Post Approval
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-research-cycle3.png)
Most relevant for: Cancer patients who are experiencing fatigue related to cancer or its treatment.
Many cancer survivors experience fatigue during and after they complete treatment. This study looked at the effect of home-based physical activity on fatigue in cancer survivors. It also looked at whether frequent counseling encouraged people to start and continue their exercise routines. (Posted 8/1/22). Este artículo está disponible en español.
Read More![](https://www.facingourrisk.org/cdn-cgi/image/width=400,height=400,fit=contain,format=webp/uploads/assets/xray/62e99334b323a.jpg)
Relevance: High
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-simple.png)
Strength of Science: Medium-High
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-simple.png)
Research Timeline: Post Approval
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-research-cycle3.png)
Study : The hidden financial burden of treating cancer care symptoms
Relevance: High
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-simple.png)
Strength of Science: Medium-High
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-simple.png)
Research Timeline: Post Approval
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-research-cycle3.png)
Most relevant for: People who are experiencing side effects due to cancer treatment or cancer.
Drugs commonly used to treat symptoms of cancer and cancer treatment side effects can cost thousands of dollars out of pocket for patients, depending on what drugs are used. (Posted 6/29/2022). Este artículo está disponible en español.
Read More![](https://www.facingourrisk.org/cdn-cgi/image/width=400,height=400,fit=contain,format=webp/uploads/assets/xray/62bcf3f1485c5.jpg)
Relevance: Medium
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-simple.png)
Strength of Science: Medium
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-simple.png)
Research Timeline: Post Approval
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-research-cycle3.png)
Study : Do artificial sweeteners increase the risk of cancer?
Relevance: Medium
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-simple.png)
Strength of Science: Medium
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-simple.png)
Research Timeline: Post Approval
![](/images/xray/gauges/new-gauge-arrow.png)
![](/images/xray/gauges/XRAYS-gauge-research-cycle3.png)
Most relevant for: People who consume artificial sweeteners
A large study of adults in France suggests that artificial sweeteners may increase the risk of certain cancers. (posted 6/21/2022). Este artículo está disponible en español.
Read More![](https://www.facingourrisk.org/cdn-cgi/image/width=400,height=400,fit=contain,format=webp/uploads/assets/xray/62b21ad6d74d3.jpg)
Search XRAY studies and Articles
This Portal Sponsored By:
![AstraZeneca](/uploads/assets/xray/sponsors/607a55cab001c.jpg?h=300&w=100&fit=contain&fm=webp)